BofA downgraded Albemarle (ALB) to Neutral from Buy with a price target of $100, up from $95. The firm sees the stock as “fairly valued” following strength as a result of the U.S. government investment in Thacker Pass and export restriction headlines on Chinese lithium batteries, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Early notable gainers among liquid option names on October 13th
- Early notable gainers among liquid option names on October 9th
- Albemarle price target raised to $85 from $70 at TD Cowen
- Albemarle Faces Near-Term EBITDA Pressure Amid Lithium Market Challenges Despite Cost-Cutting Efforts
- Albemarle price target lowered to $85 from $89 at UBS